ACLX
Price
$65.66
Change
-$0.19 (-0.29%)
Updated
Jan 23, 03:51 PM (EDT)
Capitalization
3.56B
56 days until earnings call
GLTO
Price
$5.35
Change
-$0.15 (-2.73%)
Updated
Jan 23, 03:52 PM (EDT)
Capitalization
7.24M
Ad is loading...

ACLX vs GLTO

Header iconACLX vs GLTO Comparison
Open Charts ACLX vs GLTOBanner chart's image
Arcellx
Price$65.66
Change-$0.19 (-0.29%)
Volume$474
Capitalization3.56B
Galecto
Price$5.35
Change-$0.15 (-2.73%)
Volume$1K
Capitalization7.24M
ACLX vs GLTO Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. GLTO commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and GLTO is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (ACLX: $65.85 vs. GLTO: $5.50)
Brand notoriety: ACLX and GLTO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 162% vs. GLTO: 90%
Market capitalization -- ACLX: $3.56B vs. GLTO: $7.24M
ACLX [@Biotechnology] is valued at $3.56B. GLTO’s [@Biotechnology] market capitalization is $7.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileGLTO’s FA Score has 1 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • GLTO’s FA Score: 1 green, 4 red.
According to our system of comparison, GLTO is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while GLTO’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 3 bearish.
  • GLTO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ACLX and GLTO are a good buy in the short-term.

Price Growth

ACLX (@Biotechnology) experienced а -2.46% price change this week, while GLTO (@Biotechnology) price change was +14.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +3.23%, and the average quarterly price growth was -1.09%.

Reported Earning Dates

ACLX is expected to report earnings on May 08, 2025.

GLTO is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.56B) has a higher market cap than GLTO($7.24M). GLTO YTD gains are higher at: 18.280 vs. ACLX (-14.135). GLTO has higher annual earnings (EBITDA): -19.68M vs. ACLX (-33.12M). ACLX has more cash in the bank: 574M vs. GLTO (19.7M). GLTO has less debt than ACLX: GLTO (32K) vs ACLX (65.3M). ACLX has higher revenues than GLTO: ACLX (156M) vs GLTO (0).
ACLXGLTOACLX / GLTO
Capitalization3.56B7.24M49,165%
EBITDA-33.12M-19.68M168%
Gain YTD-14.13518.280-77%
P/E RatioN/AN/A-
Revenue156M0-
Total Cash574M19.7M2,914%
Total Debt65.3M32K204,063%
TECHNICAL ANALYSIS
Technical Analysis
ACLXGLTO
RSI
ODDS (%)
N/A
Bullish Trend 16 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 16 days ago
88%
Bearish Trend 16 days ago
90%
Momentum
ODDS (%)
Bearish Trend 16 days ago
68%
Bullish Trend 16 days ago
78%
MACD
ODDS (%)
Bearish Trend 16 days ago
88%
Bullish Trend 16 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 16 days ago
75%
Bullish Trend 16 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
72%
Bearish Trend 16 days ago
90%
Advances
ODDS (%)
Bullish Trend 21 days ago
89%
Bullish Trend 22 days ago
79%
Declines
ODDS (%)
Bearish Trend 24 days ago
76%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 16 days ago
82%
Bearish Trend 16 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 16 days ago
90%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VCTR67.830.25
+0.37%
Victory Capital Holdings
SUPV17.76-0.06
-0.34%
Grupo Supervielle SA
OPBK15.79-0.17
-1.07%
OP Bancorp
JWEL2.98-0.07
-2.30%
Jowell Global Ltd
DOC20.55-0.57
-2.70%
Healthpeak Properties

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-1.08%
DNLI - ACLX
49%
Loosely correlated
+1.17%
KYMR - ACLX
47%
Loosely correlated
+0.98%
RCKT - ACLX
47%
Loosely correlated
+3.15%
RCUS - ACLX
46%
Loosely correlated
-5.23%
BEAM - ACLX
46%
Loosely correlated
+7.58%
More

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been loosely correlated with ACLX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if GLTO jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
-4.51%
ACLX - GLTO
34%
Loosely correlated
-1.08%
SYRE - GLTO
30%
Poorly correlated
-2.06%
FULC - GLTO
30%
Poorly correlated
+2.25%
XNCR - GLTO
30%
Poorly correlated
+1.08%
INMB - GLTO
30%
Poorly correlated
+17.55%
More